What does Docteur GRANDJEAN Camille do?

Docteur GRANDJEAN Camille is a general practice in Gouvy. Private Limited, started on 5 November 2021, 1 establishment.

What is the address of Docteur GRANDJEAN Camille?

The registered office of Docteur GRANDJEAN Camille is located at Courtil 103, 6671 Gouvy.

Is Docteur GRANDJEAN Camille still active?

Yes. According to the CBE (26 September 2026) Docteur GRANDJEAN Camille is active, legal situation “Normale toestand”, started on 5 November 2021.

Is Docteur GRANDJEAN Camille registered on Peppol?

Yes, Docteur GRANDJEAN Camille is registered on the Peppol network with ID 0208:0776859340.

What is the enterprise number of Docteur GRANDJEAN Camille?

The enterprise number of Docteur GRANDJEAN Camille is BE0776859340.

When was Docteur GRANDJEAN Camille founded?

Docteur GRANDJEAN Camille was founded on 5 November 2021.

Who are the directors of Docteur GRANDJEAN Camille?

According to the 2025 annual accounts, the directors of Docteur GRANDJEAN Camille are: Camille Grandjean.

Is Docteur GRANDJEAN Camille a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 November 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur GRANDJEAN Camille make in 2025?

Docteur GRANDJEAN Camille posted a profit after taxes of € 36,613 in financial year 2025.

What is the revenue of Docteur GRANDJEAN Camille?

As a small company, Docteur GRANDJEAN Camille is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 46,577.

Docteur GRANDJEAN Camille (Private Limited) - Gouvy

Dossier Docteur GRANDJEAN Camille, printed on 26 September 2026 from databakkes.be/en/0776859340/docteur-grandjean-camille. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Docteur GRANDJEAN Camille from Gouvy, company number BE0776859340, closed financial year 2025 with a result of € 36,613 after tax. For that financial year Docteur GRANDJEAN Camille recorded a gross margin of € 46,577 and equity of € 68,831. Compared with financial year 2024, the result moved from € 70,839 to € 36,613. The company is profitable. The buffer shrank hard: equity is 62 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Shrank hard

€ 68,831

▼ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 36,613

▼ 48% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 92,610

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 151,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 25,273

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,202

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 30,016

▲ € 23,534 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 59,790 Gross margin 2022: € 59,790 First fiscal year in the series	€ 84,979 Gross margin 2023: € 84,979 ▲ 42% vs 2022 (€ 59,790) Favourable step	€ 90,914 Gross margin 2024: € 90,914 ▲ 7% vs 2023 (€ 84,979) Favourable step	€ 46,577 Gross margin 2025: € 46,577 ▼ 49% vs 2024 (€ 90,914) Unfavourable step	▼ 49%
Profit after taxes	€ 44,609 Profit after taxes 2022: € 44,609 First fiscal year in the series	€ 67,700 Profit after taxes 2023: € 67,700 ▲ 52% vs 2022 (€ 44,609) Favourable step	€ 70,839 Profit after taxes 2024: € 70,839 ▲ 5% vs 2023 (€ 67,700) Favourable step	€ 36,613 Profit after taxes 2025: € 36,613 ▼ 48% vs 2024 (€ 70,839) Unfavourable step	▼ 48%
Equity	€ 46,309 Equity 2022: € 46,309 First fiscal year in the series	€ 113,209 Equity 2023: € 113,209 ▲ 144% vs 2022 (€ 46,309) Favourable step	€ 183,218 Equity 2024: € 183,218 ▲ 62% vs 2023 (€ 113,209) Favourable step	€ 68,831 Equity 2025: € 68,831 ▼ 62% vs 2024 (€ 183,218) Unfavourable step	▼ 62%
Total debts	€ 34,190 Total debts 2022: € 34,190 First fiscal year in the series	€ 9,234 Total debts 2023: € 9,234 ▼ 73% vs 2022 (€ 34,190) Favourable step	€ 11,265 Total debts 2024: € 11,265 ▲ 22% vs 2023 (€ 9,234) Unfavourable step	€ 163,258 Total debts 2025: € 163,258 ▲ € 151,994 vs 2024 (€ 11,265) Unfavourable step	▲ € 151,994
Cash	€ 63,261 Cash 2022: € 63,261 First fiscal year in the series	€ 102,843 Cash 2023: € 102,843 ▲ 63% vs 2022 (€ 63,261) Favourable step	€ 83,502 Cash 2024: € 83,502 ▼ 19% vs 2023 (€ 102,843) Unfavourable step	€ 92,610 Cash 2025: € 92,610 ▲ 11% vs 2024 (€ 83,502) Favourable step	▲ 11%
Retained profit	€ 43,809 Retained profit 2022: € 43,809 First fiscal year in the series	€ 110,709 Retained profit 2023: € 110,709 ▲ 153% vs 2022 (€ 43,809) Favourable step	€ 180,718 Retained profit 2024: € 180,718 ▲ 63% vs 2023 (€ 110,709) Favourable step	€ 66,331 Retained profit 2025: € 66,331 ▼ 63% vs 2024 (€ 180,718) Unfavourable step	▼ 63%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 830 Dividend 2024: € 830 ▲ 4% vs 2023 (€ 800) Unchanged	€ 151,000 Dividend 2025: € 151,000 ▲ € 150,170 vs 2024 (€ 830) Unchanged	▲ € 150,170
Balance sheet total	€ 80,499 Balance sheet total 2022: € 80,499 First fiscal year in the series	€ 122,442 Balance sheet total 2023: € 122,442 ▲ 52% vs 2022 (€ 80,499) Unchanged	€ 194,483 Balance sheet total 2024: € 194,483 ▲ 59% vs 2023 (€ 122,442) Unchanged	€ 232,089 Balance sheet total 2025: € 232,089 ▲ 19% vs 2024 (€ 194,483) Unchanged	▲ 19%

Key figures of Docteur GRANDJEAN Camille, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur GRANDJEAN Camille?

What happened at Docteur GRANDJEAN Camille in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 29, 2026 New annual accounts for financial year 2025: profit of € 36,613 (▼ 48% vs 2024). Source: NBB ↗
Nov 5, 2021 New establishment in Gouvy. KBO
2021 Camille Grandjean became a director. NBB
Nov 5, 2021 Start of the company according to the CBE. KBO

In short

From € 44,609 profit in 2022 to € 36,613 profit in 2025.

Paid € 63,356 in corporate taxes since 2022.

Best year ever: 2024, with € 70,839 profit.

Paid out € 153,430 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur GRANDJEAN Camille? We notify you, reason included.

Follow Docteur GRANDJEAN Camille

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Camille Grandjean

Docteur GRANDJEAN Camille

Behind Docteur GRANDJEAN Camille is Camille Grandjean.

See the full network in the app

Directors

According to the 2025 annual accounts

Camille Grandjean

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Courtil 103

6671 Gouvy

2.324.316.275

Rue de Bellain,Limerlé 2 box a

6670 Gouvy

Active since 5 November 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.859.340
VAT number: BE 0776.859.340
Registered office: Courtil 103, 6671 Gouvy
Names & denominations: Docteur GRANDJEAN Camille
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 November 2021
Peppol: Active · Active since 27 Apr 2026
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗